{"database": "lobbying", "table": "lobbying_activities", "rows": [[2838453, "178f6e09-20fd-4096-8fa0-f6bf64e0da62", "Q2", "BUCHANAN INGERSOLL & ROONEY PC", 55291, "GENERIC ANIMAL DRUG ALLIANCE", 2022, "second_quarter", "ANI", "Strategy development and implementation of federal government relations initiatives relating to generic animal drug industry.", "Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE", 30000, null, 0, 0, "2022-07-20T11:09:43-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2838453"], "units": {}, "query_ms": 48.13600005581975, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}